CureVac N.V (NASDAQ:CVAC) shares, rose in value on Thursday, January 02, with the stock price up by 5.13% to the previous day’s close as strong demand from buyers drove the stock to $3.59.
Actively observing the price movement in the recent trading, the stock is buoying the session at $3.41, falling within a range of $3.33 and $3.61. The value of beta (5-year monthly) is 2.611 whereas the PE ratio is 6.60 over 12-month period. Referring to stock’s 52-week performance, its high was $5.28, and the low was $2.21. On the whole, CVAC has fluctuated by 22.77% over the past month.
With the market capitalization of CureVac N.V currently standing at about $804.13 million, investors are eagerly awaiting this quarter’s results, scheduled for in February.
Wall Street analysts also predicted that the company’s y-o-y revenues would reach 6.5M.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that CVAC’s technical picture suggests that short-term indicators denote the stock is a 50% Buy on average. However, medium-term indicators have put the stock in the category of 50% Sell while long-term indicators on average have been pointing out that it is a 50% Buy.
The stock’s technical analysis shows that the price of CVAC currently trading nearly 15.31% and 23.85% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 68.11, while the 7-day volatility ratio is showing 6.19% which for the 30-day chart, stands at 6.59%. Furthermore, CureVac N.V (CVAC)’s beta value is 2.49, and its average true range (ATR) is 0.20.
A comparison of CureVac N.V (CVAC) with its peers suggests the former has fared considerably weaker in the market. CVAC showed an intraday change of 5.13% in today’s session so far, and over the past year, it shrunk by -14.44%%.
Data on historical trading for CureVac N.V (NASDAQ:CVAC) indicates that the trading volumes over the past 10 days have averaged 0.62 and over the past 3 months, they’ve averaged 504.28K. According to company’s latest data on outstanding shares, there are 224.34 million shares outstanding.
Nearly 58.26% of CureVac N.V’s shares belong to company insiders and institutional investors own 5.18% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 3.94 million shares as on 2024-12-13, resulting in a short ratio of 6.65. According to the data, the short interest in CureVac N.V (CVAC) stood at 982.00 of shares outstanding as of 2024-12-13; the number of short shares registered in 2024-11-15 reached 4.41 million. The stock has risen by 5.13% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the CVAC stock heading into the next quarter.
